APO Research
Talk to an analyst

APO RESEARCH · REPORT

Strep Throat Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Strep Throat Treatment Drugs Market Outlook and Growth Opportunities 2026

21 December 2025195 pages

Choose your research edition.

Industry ResearchStrep Throat Treatment Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Strep Throat Treatment Drugs Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Strep Throat Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Strep Throat Treatment Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Strep Throat Treatment Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Strep Throat Treatment Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Strep Throat Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Strep Throat Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Strep Throat Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Strep Throat Treatment Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Strep Throat Treatment Drugs market include Johnson & Johnson, Novartis, Merck & co., Roche, Eli Lily, Pfizer, Bayer, Bristol-Myers Squibb and Astra Zeneca, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Strep Throat Treatment Drugs market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Strep Throat Treatment Drugs and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Strep Throat Treatment Drugs revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Strep Throat Treatment Drugs market.

Strep Throat Treatment Drugs Segment by Company

Johnson & Johnson

Novartis

Merck & co.

Roche

Eli Lily

Pfizer

Bayer

Bristol-Myers Squibb

Astra Zeneca

Bausch Health

Abbott Laboratories

Strep Throat Treatment Drugs Segment by Type

Penicillin

Amoxicillin

Strep Throat Treatment Drugs Segment by Application

Specialty Clinics

Diagnostic Laboratories

Hospitals

Strep Throat Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Strep Throat Treatment Drugs status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Strep Throat Treatment Drugs key companies, revenue, market share, and recent developments.

3. To split the Strep Throat Treatment Drugs breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Strep Throat Treatment Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Strep Throat Treatment Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Strep Throat Treatment Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Strep Throat Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Strep Throat Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Strep Throat Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Strep Throat Treatment Drugs industry.

Chapter 3: Detailed analysis of Strep Throat Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Strep Throat Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Strep Throat Treatment Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Strep Throat Treatment Drugs Industry Trends Table 2. Strep Throat Treatment Drugs Industry Drivers Table 3. Strep Throat Treatment Drugs Industry Opportunities and Challenges Table 4. Strep Throat Treatment Drugs Industry Restraints Table 5. Global Strep Throat Treatment Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Strep Throat Treatment Drugs Revenue Share by Company (2021-2026) Table 7. Global Strep Throat Treatment Drugs Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Strep Throat Treatment Drugs Key Company Manufacturing Base & Headquarters Table 9. Global Strep Throat Treatment Drugs Company, Product Type & Application Table 10. Global Strep Throat Treatment Drugs Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Strep Throat Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Penicillin Table 15. Significant Companies of Amoxicillin Table 16. Global Strep Throat Treatment Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Strep Throat Treatment Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Strep Throat Treatment Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Strep Throat Treatment Drugs Sales Value Share by Type (2021-2026) Table 20. Global Strep Throat Treatment Drugs Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Specialty Clinics Table 22. Significant Companies of Diagnostic Laboratories Table 23. Significant Companies of Hospitals Table 24. Global Strep Throat Treatment Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Strep Throat Treatment Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Strep Throat Treatment Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Strep Throat Treatment Drugs Sales Value Share by Application (2021-2026) Table 28. Global Strep Throat Treatment Drugs Sales Value Share by Application (2027-2032) Table 29. Global Strep Throat Treatment Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Strep Throat Treatment Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Strep Throat Treatment Drugs Sales Value Share by Region (2021-2026) Table 32. Global Strep Throat Treatment Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Strep Throat Treatment Drugs Sales Value Share by Region (2027-2032) Table 34. Global Strep Throat Treatment Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Strep Throat Treatment Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Strep Throat Treatment Drugs Sales Value Market Share by Country (2021-2026) Table 37. Global Strep Throat Treatment Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Strep Throat Treatment Drugs Sales Value Market Share by Country (2027-2032) Table 39. Johnson & Johnson Company Information Table 40. Johnson & Johnson Business Overview Table 41. Johnson & Johnson Strep Throat Treatment Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Johnson & Johnson Strep Throat Treatment Drugs Product Portfolio Table 43. Johnson & Johnson Recent Development Table 44. Novartis Company Information Table 45. Novartis Business Overview Table 46. Novartis Strep Throat Treatment Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Novartis Strep Throat Treatment Drugs Product Portfolio Table 48. Novartis Recent Development Table 49. Merck & co. Company Information Table 50. Merck & co. Business Overview Table 51. Merck & co. Strep Throat Treatment Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Merck & co. Strep Throat Treatment Drugs Product Portfolio Table 53. Merck & co. Recent Development Table 54. Roche Company Information Table 55. Roche Business Overview Table 56. Roche Strep Throat Treatment Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Roche Strep Throat Treatment Drugs Product Portfolio Table 58. Roche Recent Development Table 59. Eli Lily Company Information Table 60. Eli Lily Business Overview Table 61. Eli Lily Strep Throat Treatment Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Eli Lily Strep Throat Treatment Drugs Product Portfolio Table 63. Eli Lily Recent Development Table 64. Pfizer Company Information Table 65. Pfizer Business Overview Table 66. Pfizer Strep Throat Treatment Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Pfizer Strep Throat Treatment Drugs Product Portfolio Table 68. Pfizer Recent Development Table 69. Bayer Company Information Table 70. Bayer Business Overview Table 71. Bayer Strep Throat Treatment Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Bayer Strep Throat Treatment Drugs Product Portfolio Table 73. Bayer Recent Development Table 74. Bristol-Myers Squibb Company Information Table 75. Bristol-Myers Squibb Business Overview Table 76. Bristol-Myers Squibb Strep Throat Treatment Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Bristol-Myers Squibb Strep Throat Treatment Drugs Product Portfolio Table 78. Bristol-Myers Squibb Recent Development Table 79. Astra Zeneca Company Information Table 80. Astra Zeneca Business Overview Table 81. Astra Zeneca Strep Throat Treatment Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Astra Zeneca Strep Throat Treatment Drugs Product Portfolio Table 83. Astra Zeneca Recent Development Table 84. Bausch Health Company Information Table 85. Bausch Health Business Overview Table 86. Bausch Health Strep Throat Treatment Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Bausch Health Strep Throat Treatment Drugs Product Portfolio Table 88. Bausch Health Recent Development Table 89. Abbott Laboratories Company Information Table 90. Abbott Laboratories Business Overview Table 91. Abbott Laboratories Strep Throat Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Abbott Laboratories Strep Throat Treatment Drugs Product Portfolio Table 93. Abbott Laboratories Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Strep Throat Treatment Drugs Product Image Figure 2. Global Strep Throat Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Strep Throat Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Strep Throat Treatment Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Penicillin Image Figure 8. Amoxicillin Image Figure 9. Global Strep Throat Treatment Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Strep Throat Treatment Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Strep Throat Treatment Drugs Sales Value Share by Type (2021-2032) Figure 12. Specialty Clinics Image Figure 13. Diagnostic Laboratories Image Figure 14. Hospitals Image Figure 15. Global Strep Throat Treatment Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Strep Throat Treatment Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Strep Throat Treatment Drugs Sales Value Share by Application (2021-2032) Figure 18. Global Strep Throat Treatment Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Strep Throat Treatment Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Strep Throat Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 21. North America Strep Throat Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Strep Throat Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Strep Throat Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Strep Throat Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Strep Throat Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Strep Throat Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 27. South America Strep Throat Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Strep Throat Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Strep Throat Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Penicillin
  • Amoxicillin
Applications
  • Specialty Clinics
  • Diagnostic Laboratories
  • Hospitals
Companies covered
  • Johnson & Johnson
  • Novartis
  • Merck & co.
  • Roche
  • Eli Lily
  • Pfizer
  • Bayer
  • Bristol-Myers Squibb
  • Astra Zeneca
  • Bausch Health
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Strep Throat Treatment Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Strep Throat Treatment Drugs Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Strep Throat Treatment Drugs Market Dynamics
  1. 2.1 Strep Throat Treatment Drugs Industry Trends
  2. 2.2 Strep Throat Treatment Drugs Industry Drivers
  3. 2.3 Strep Throat Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Strep Throat Treatment Drugs Industry Restraints
3 Strep Throat Treatment Drugs Market by Company
  1. 3.1 Global Strep Throat Treatment Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Strep Throat Treatment Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Strep Throat Treatment Drugs Company Ranking (2024-2026)
  4. 3.4 Global Strep Throat Treatment Drugs Company Manufacturing Base and Headquarters
  5. 3.5 Global Strep Throat Treatment Drugs Company Product Type and Application
  6. 3.6 Global Strep Throat Treatment Drugs Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Strep Throat Treatment Drugs Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Strep Throat Treatment Drugs Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Strep Throat Treatment Drugs Market by Type
  1. 4.1 Strep Throat Treatment Drugs Type Introduction
  2. 4.1.1 Penicillin
  3. 4.1.2 Amoxicillin
  4. 4.2 Global Strep Throat Treatment Drugs Sales Value by Type
  5. 4.2.1 Global Strep Throat Treatment Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Strep Throat Treatment Drugs Sales Value by Type (2021-2032)
  7. 4.2.3 Global Strep Throat Treatment Drugs Sales Value Share by Type (2021-2032)
5 Strep Throat Treatment Drugs Market by Application
  1. 5.1 Strep Throat Treatment Drugs Application Introduction
  2. 5.1.1 Specialty Clinics
  3. 5.1.2 Diagnostic Laboratories
  4. 5.1.3 Hospitals
  5. 5.2 Global Strep Throat Treatment Drugs Sales Value by Application
  6. 5.2.1 Global Strep Throat Treatment Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Strep Throat Treatment Drugs Sales Value by Application (2021-2032)
  8. 5.2.3 Global Strep Throat Treatment Drugs Sales Value Share by Application (2021-2032)
6 Strep Throat Treatment Drugs Regional Value Analysis
  1. 6.1 Global Strep Throat Treatment Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Strep Throat Treatment Drugs Sales Value by Region (2021-2032)
  3. 6.2.1 Global Strep Throat Treatment Drugs Sales Value by Region: 2021-2026
  4. 6.2.2 Global Strep Throat Treatment Drugs Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Strep Throat Treatment Drugs Sales Value (2021-2032)
  7. 6.3.2 North America Strep Throat Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Strep Throat Treatment Drugs Sales Value (2021-2032)
  10. 6.4.2 Europe Strep Throat Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Strep Throat Treatment Drugs Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Strep Throat Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Strep Throat Treatment Drugs Sales Value (2021-2032)
  16. 6.6.2 South America Strep Throat Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Strep Throat Treatment Drugs Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Strep Throat Treatment Drugs Sales Value Share by Country, 2025 VS 2032
7 Strep Throat Treatment Drugs Country-level Value Analysis
  1. 7.1 Global Strep Throat Treatment Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Strep Throat Treatment Drugs Sales Value by Country (2021-2032)
  3. 7.2.1 Global Strep Throat Treatment Drugs Sales Value by Country (2021-2026)
  4. 7.2.2 Global Strep Throat Treatment Drugs Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Strep Throat Treatment Drugs Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Strep Throat Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Strep Throat Treatment Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Strep Throat Treatment Drugs Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Strep Throat Treatment Drugs Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Merck & co.
  14. 8.3.1 Merck & co. Company Information
  15. 8.3.2 Merck & co. Business Overview
  16. 8.3.3 Merck & co. Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck & co. Strep Throat Treatment Drugs Product Portfolio
  18. 8.3.5 Merck & co. Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Strep Throat Treatment Drugs Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Eli Lily
  26. 8.5.1 Eli Lily Company Information
  27. 8.5.2 Eli Lily Business Overview
  28. 8.5.3 Eli Lily Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eli Lily Strep Throat Treatment Drugs Product Portfolio
  30. 8.5.5 Eli Lily Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Strep Throat Treatment Drugs Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Strep Throat Treatment Drugs Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 Bristol-Myers Squibb
  44. 8.8.1 Bristol-Myers Squibb Company Information
  45. 8.8.2 Bristol-Myers Squibb Business Overview
  46. 8.8.3 Bristol-Myers Squibb Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bristol-Myers Squibb Strep Throat Treatment Drugs Product Portfolio
  48. 8.8.5 Bristol-Myers Squibb Recent Developments
  49. 8.9 Astra Zeneca
  50. 8.9.1 Astra Zeneca Company Information
  51. 8.9.2 Astra Zeneca Business Overview
  52. 8.9.3 Astra Zeneca Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Astra Zeneca Strep Throat Treatment Drugs Product Portfolio
  54. 8.9.5 Astra Zeneca Recent Developments
  55. 8.10 Bausch Health
  56. 8.10.1 Bausch Health Company Information
  57. 8.10.2 Bausch Health Business Overview
  58. 8.10.3 Bausch Health Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bausch Health Strep Throat Treatment Drugs Product Portfolio
  60. 8.10.5 Bausch Health Recent Developments
  61. 8.11 Abbott Laboratories
  62. 8.11.1 Abbott Laboratories Company Information
  63. 8.11.2 Abbott Laboratories Business Overview
  64. 8.11.3 Abbott Laboratories Strep Throat Treatment Drugs Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Abbott Laboratories Strep Throat Treatment Drugs Product Portfolio
  66. 8.11.5 Abbott Laboratories Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst